{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T18:55:34Z","timestamp":1789239334730,"version":"build-2803163510"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12033-024-01347-8","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:30:01Z","timestamp":1734953401000},"page":"4403-4417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Interleukin in Immune-Mediated Diseases: An Updated Review"],"prefix":"10.1007","volume":"67","author":[{"family":"Zaroon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakira","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Hafsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1172-5117","authenticated-orcid":false,"given":"Hamid","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","volume":"39","author":"C Dong","year":"2021","unstructured":"Dong, C. (2021). Cytokine regulation and function in T cells. Annual Review of Immunology, 39, 51\u201376.","journal-title":"Annual Review of Immunology"},{"issue":"4","key":"1347_CR2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"EDT Wojno","year":"2019","unstructured":"Wojno, E. D. T., Hunter, C. A., & Stumhofer, J. S. (2019). The immunobiology of the interleukin-12 family: Room for discovery. Immunity, 50(4), 851\u2013870.","journal-title":"Immunity"},{"key":"1347_CR3","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross, S. H., & Cantrell, D. A. (2018). Signaling and function of interleukin-2 in T lymphocytes. Annual Review of Immunology, 36, 411\u2013433.","journal-title":"Annual Review of Immunology"},{"issue":"12","key":"1347_CR4","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1002\/pro.3519","volume":"27","author":"R Morris","year":"2018","unstructured":"Morris, R., Kershaw, N. J., & Babon, J. J. (2018). The molecular details of cytokine signaling via the JAK\/STAT pathway. Protein Science, 27(12), 1984\u20132009.","journal-title":"Protein Science"},{"key":"1347_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109946","volume":"125","author":"Y-S Chai","year":"2020","unstructured":"Chai, Y.-S., et al. (2020). Curcumin regulates the differentiation of na\u00efve CD4+ T cells and activates IL-10 immune modulation against acute lung injury in mice. Biomedicine & Pharmacotherapy, 125, 109946.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"1347_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/cells9020433","volume":"9","author":"F Franke","year":"2020","unstructured":"Franke, F., Kirchenbaum, G. A., Kuerten, S., & Lehmann, P. V. (2020). IL-21 in conjunction with anti-CD40 and IL-4 constitutes a potent polyclonal B cell stimulator for monitoring antigen-specific memory B cells. Cells, 9(2), 433.","journal-title":"Cells"},{"issue":"38","key":"1347_CR7","doi-asserted-by":"publisher","first-page":"eaav3866","DOI":"10.1126\/sciimmunol.aav3866","volume":"4","author":"A Sliz","year":"2019","unstructured":"Sliz, A., et al. (2019). Gab3 is required for IL-2\u2013and IL-15\u2013induced NK cell expansion and limits trophoblast invasion during pregnancy. Science Immunology, 4(38), eaav3866.","journal-title":"Science Immunology"},{"issue":"4","key":"1347_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1089\/wound.2019.1032","volume":"9","author":"EH Steen","year":"2020","unstructured":"Steen, E. H., et al. (2020). The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis. Advances in Wound Care, 9(4), 184\u2013198.","journal-title":"Advances in Wound Care"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijbiomac.2021.02.131","volume":"177","author":"E Fathi","year":"2021","unstructured":"Fathi, E., Farahzadi, R., & Valipour, B. (2021). Alginate\/gelatin encapsulation promotes NK cells differentiation potential of bone marrow resident C-kit+ hematopoietic stem cells. International Journal of Biological Macromolecules, 177, 317\u2013327.","journal-title":"International Journal of Biological Macromolecules"},{"issue":"11","key":"1347_CR10","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/cmi.2016.59","volume":"14","author":"K-A Cho","year":"2017","unstructured":"Cho, K.-A., et al. (2017). Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner. Cellular & Molecular Immunology, 14(11), 895\u2013908.","journal-title":"Cellular & Molecular Immunology"},{"issue":"2","key":"1347_CR11","doi-asserted-by":"publisher","first-page":"e000973","DOI":"10.1136\/jitc-2020-000973","volume":"8","author":"L Shi","year":"2020","unstructured":"Shi, L., et al. (2020). Combining IL-2-based immunotherapy with commensal probiotics produces enhanced antitumor immune response and tumor clearance. Journal for Immunotherapy of Cancer, 8(2), e000973.","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/B978-0-12-821671-2.00016-7","volume-title":"Lanzkowsky\u2019s Manual of pediatric hematology and oncology","author":"C McGuinn","year":"2022","unstructured":"McGuinn, C., & Bussel, J. B. (2022). Disorders of platelets. Lanzkowsky\u2019s Manual of pediatric hematology and oncology (pp. 237\u2013285). Elsevier."},{"key":"1347_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/9783527826759.ch6","author":"RJ Truscott","year":"2021","unstructured":"Truscott, R. J. (2021). Degradation of long-lived proteins as a cause of autoimmune diseases. Long-Lived Proteins in Human Aging and Disease. https:\/\/doi.org\/10.1002\/9783527826759.ch6","journal-title":"Long-Lived Proteins in Human Aging and Disease"},{"key":"1347_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.656362","volume":"12","author":"F Ferretti","year":"2021","unstructured":"Ferretti, F., et al. (2021). How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: An expert opinion by IMIDs study group. Frontiers in Immunology, 12, 656362.","journal-title":"Frontiers in Immunology"},{"key":"1347_CR15","unstructured":"Pahwa, R., A. Goyal, P. Bansal, and I. Jialal, Chronic inflammation. 2018."},{"issue":"2","key":"1347_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102743","volume":"20","author":"ZX Xiao","year":"2021","unstructured":"Xiao, Z. X., Miller, J. S., & Zheng, S. G. (2021). An updated advance of autoantibodies in autoimmune diseases. Autoimmunity Reviews, 20(2), 102743.","journal-title":"Autoimmunity Reviews"},{"key":"1347_CR17","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3389\/fimmu.2018.02807","volume":"9","author":"J L\u00fcbbers","year":"2018","unstructured":"L\u00fcbbers, J., Rodr\u00edguez, E., & Van Kooyk, Y. (2018). Modulation of immune tolerance via siglec-sialic acid interactions. Frontiers in Immunology, 9, 2807.","journal-title":"Frontiers in Immunology"},{"key":"1347_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jri.2017.09.005","volume":"123","author":"EA Bonney","year":"2017","unstructured":"Bonney, E. A. (2017). Alternative theories: Pregnancy and immune tolerance. Journal of Reproductive Immunology, 123, 65\u201371.","journal-title":"Journal of Reproductive Immunology"},{"issue":"3","key":"1347_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102459","volume":"19","author":"A Vojdani","year":"2020","unstructured":"Vojdani, A., Gushgari, L. R., & Vojdani, E. (2020). Interaction between food antigens and the immune system: Association with autoimmune disorders. Autoimmunity Reviews, 19(3), 102459.","journal-title":"Autoimmunity Reviews"},{"key":"1347_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.635527","volume":"9","author":"T Marchini","year":"2021","unstructured":"Marchini, T., Mitre, L. S., & Wolf, D. (2021). Inflammatory cell recruitment in cardiovascular disease. Frontiers in Cell and Developmental Biology, 9, 635527.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"1","key":"1347_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/imr.12752","volume":"289","author":"T L\u00e4mmermann","year":"2019","unstructured":"L\u00e4mmermann, T., & Kastenm\u00fcller, W. (2019). Concepts of GPCR-controlled navigation in the immune system. Immunological Reviews, 289(1), 205\u2013231.","journal-title":"Immunological Reviews"},{"issue":"27","key":"1347_CR22","doi-asserted-by":"publisher","first-page":"15935","DOI":"10.1073\/pnas.2004615117","volume":"117","author":"MJ Tuazon Kels","year":"2020","unstructured":"Tuazon Kels, M. J., et al. (2020). TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection. Proceedings of the National Academy of Sciences, 117(27), 15935\u201315946.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"1347_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-981-10-4284-3_10","volume":"2","author":"B Bhavya","year":"2017","unstructured":"Bhavya, B., & Haridas, M. (2017). Anti-inflammatory molecules: Immune system mediators. Bioresources and Bioprocess in Biotechnology: Exploring Potential Biomolecules, 2, 235\u2013268.","journal-title":"Bioresources and Bioprocess in Biotechnology: Exploring Potential Biomolecules"},{"issue":"4","key":"1347_CR24","doi-asserted-by":"publisher","first-page":"4924","DOI":"10.1002\/jcp.27290","volume":"234","author":"S AbdolmohammadiVahid","year":"2019","unstructured":"AbdolmohammadiVahid, S., et al. (2019). Altered T-cell subpopulations in recurrent pregnancy loss patients with cellular immune abnormalities. Journal of Cellular Physiology, 234(4), 4924\u20134933.","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"1347_CR25","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.4049\/jimmunol.1500350","volume":"198","author":"M Douaisi","year":"2017","unstructured":"Douaisi, M., et al. (2017). CD31, a valuable marker to identify early and late stages of T cell differentiation in the human thymus. The Journal of Immunology, 198(6), 2310\u20132319.","journal-title":"The Journal of Immunology"},{"issue":"4","key":"1347_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S., & Schumacher, T. N. (2018). T cell dysfunction in cancer. Cancer Cell, 33(4), 547\u2013562.","journal-title":"Cancer Cell"},{"key":"1347_CR27","volume-title":"Seminars in immunology","author":"C Neumann","year":"2019","unstructured":"Neumann, C., Scheffold, A., & Rutz, S. (2019). Functions and regulation of T cell-derived interleukin-10. Seminars in immunology. Elsevier."},{"key":"1347_CR28","volume-title":"Seminars in immunopathology","author":"JR Teijaro","year":"2017","unstructured":"Teijaro, J. R. (2017). Cytokine storms in infectious diseases. Seminars in immunopathology. Springer."},{"issue":"D1","key":"1347_CR29","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","volume":"45","author":"G Koscielny","year":"2017","unstructured":"Koscielny, G., et al. (2017). Open Targets: A platform for therapeutic target identification and validation. Nucleic acids research, 45(D1), D985\u2013D994.","journal-title":"Nucleic acids research"},{"key":"1347_CR30","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3389\/fphar.2017.00460","volume":"8","author":"P Li","year":"2017","unstructured":"Li, P., Zheng, Y., & Chen, X. (2017). Drugs for autoimmune inflammatory diseases: From small molecule compounds to anti-TNF biologics. Frontiers in Pharmacology, 8, 460.","journal-title":"Frontiers in Pharmacology"},{"issue":"10","key":"1347_CR31","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.3390\/ijms21103474","volume":"21","author":"D Gemmati","year":"2020","unstructured":"Gemmati, D., et al. (2020). COVID-19 and individual genetic susceptibility\/receptivity: Role of ACE1\/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? International Journal of Molecular Sciences, 21(10), 3474.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1347_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki, V., Kumar, V., Wijmenga, C., & Zhernakova, A. (2017). The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biology, 18(1), 1\u201321.","journal-title":"Genome Biology"},{"issue":"3","key":"1347_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2019.02.001","volume":"50","author":"D Yang","year":"2019","unstructured":"Yang, D., et al. (2019). Dysregulated lung commensal bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles. Immunity, 50(3), 692-706.e7.","journal-title":"Immunity"},{"key":"1347_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110770","volume":"123","author":"T Ouyang","year":"2023","unstructured":"Ouyang, T., et al. (2023). Potential mechanistic roles of Interleukin-33 in rheumatoid arthritis. International Immunopharmacology, 123, 110770.","journal-title":"International Immunopharmacology"},{"issue":"2","key":"1347_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/03009742.2018.1477989","volume":"48","author":"T Matsuo","year":"2019","unstructured":"Matsuo, T., et al. (2019). Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: A cross-sectional study. Scandinavian Journal of Rheumatology, 48(2), 87\u201394.","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"1347_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-016-0964-7","volume":"18","author":"TW Kragstrup","year":"2016","unstructured":"Kragstrup, T. W., et al. (2016). The interleukin-20 receptor axis in early rheumatoid arthritis: Novel links between disease-associated autoantibodies and radiographic progression. Arthritis Research & Therapy, 18, 1\u201312.","journal-title":"Arthritis Research & Therapy"},{"issue":"10","key":"1347_CR37","first-page":"3","volume":"4","author":"SI Islomovich","year":"2024","unstructured":"Islomovich, S. I. (2024). Gender characteristics of the current rheumatoid arthritis. International Journal of Medical Sciences, 4(10), 3\u20138.","journal-title":"International Journal of Medical Sciences"},{"issue":"5","key":"1347_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s40744-024-00704-y","volume":"11","author":"P Goupille","year":"2024","unstructured":"Goupille, P., CarvajalAlegria, G., Verhoeven, F., & Wendling, D. (2024). Treatment with targeted therapy in patients with psoriatic arthritis and inadequate response to methotrexate: Proposal for a rational strategy. Rheumatology and Therapy, 11(5), 1065\u20131079.","journal-title":"Rheumatology and Therapy"},{"issue":"5","key":"1347_CR39","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa2312302","volume":"391","author":"H Griffin","year":"2024","unstructured":"Griffin, H., et al. (2024). Neutralizing autoantibodies against interleukin-10 in inflammatory bowel disease. New England Journal of Medicine, 391(5), 434\u2013441.","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"1347_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00535-022-01936-x","volume":"58","author":"A Andoh","year":"2023","unstructured":"Andoh, A., & Nishida, A. (2023). Pro-and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease. Journal of Gastroenterology, 58(2), 69\u201378.","journal-title":"Journal of Gastroenterology"},{"issue":"1","key":"1347_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-022-00695-x","volume":"17","author":"A Shahini","year":"2023","unstructured":"Shahini, A., & Shahini, A. (2023). Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: Focus on the available therapeutic approaches and gut microbiome. Journal of Cell Communication and Signaling, 17(1), 55\u201374.","journal-title":"Journal of Cell Communication and Signaling"},{"issue":"11","key":"1347_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/1759720X17735756","volume":"9","author":"Y-C Tsai","year":"2017","unstructured":"Tsai, Y.-C., & Tsai, T.-F. (2017). Anti-interleukin and interleukin therapies for psoriasis: Current evidence and clinical usefulness. Therapeutic Advances in Musculoskeletal Disease, 9(11), 277\u2013294.","journal-title":"Therapeutic Advances in Musculoskeletal Disease"},{"issue":"6","key":"1347_CR43","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1365-2133.2010.09992.x","volume":"163","author":"S Coimbra","year":"2010","unstructured":"Coimbra, S., et al. (2010). Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-\u03b1 levels in patients with psoriasis before, during and after psoralen\u2013ultraviolet A and narrowband ultraviolet B therapy. British Journal of Dermatology, 163(6), 1282\u20131290.","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"1347_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","volume":"99","author":"K Ogawa","year":"2020","unstructured":"Ogawa, K., & Okada, Y. (2020). The current landscape of psoriasis genetics in 2020. Journal of Dermatological Science, 99(1), 2\u20138.","journal-title":"Journal of Dermatological Science"},{"issue":"7","key":"1347_CR45","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/cts.13283","volume":"15","author":"V Moreno-Torres","year":"2022","unstructured":"Moreno-Torres, V., et al. (2022). Serum cytokines to predict systemic lupus erythematosus clinical and serological activity. Clinical and Translational Science, 15(7), 1676\u20131686.","journal-title":"Clinical and Translational Science"},{"issue":"9","key":"1347_CR46","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/art.41737","volume":"73","author":"M Rudnik","year":"2021","unstructured":"Rudnik, M., et al. (2021). Regulation of monocyte adhesion and type I interferon signaling by CD52 in patients with systemic sclerosis. Arthritis & Rheumatology, 73(9), 1720\u20131730.","journal-title":"Arthritis & Rheumatology"},{"issue":"5","key":"1347_CR47","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/ijms25052589","volume":"25","author":"C Grunwald","year":"2024","unstructured":"Grunwald, C., et al. (2024). The role of selected interleukins in the development and progression of multiple sclerosis\u2014A systematic review. International Journal of Molecular Sciences, 25(5), 2589.","journal-title":"International Journal of Molecular Sciences"},{"key":"1347_CR48","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1201\/9781003124542-33","volume-title":"Translational medicine","author":"FR Brennan","year":"2021","unstructured":"Brennan, F. R. (2021). Non-clinical safety evaluation of immunomodulatory biological therapeutics for the treatment of immune-mediated diseases. Translational medicine (pp. 451\u2013487). CRC Press."},{"issue":"1","key":"1347_CR49","first-page":"1409069","volume":"2019","author":"A De Silvestri","year":"2019","unstructured":"De Silvestri, A., et al. (2019). The involvement of HLA class II alleles in multiple sclerosis: A systematic review with meta-analysis. Disease Markers, 2019(1), 1409069.","journal-title":"Disease Markers"},{"issue":"8","key":"1347_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161548","volume":"11","author":"N Fatima","year":"2016","unstructured":"Fatima, N., et al. (2016). Role of pro-inflammatory cytokines and biochemical markers in the pathogenesis of type 1 diabetes: Correlation with age and glycemic condition in diabetic human subjects. PLoS ONE, 11(8), e0161548.","journal-title":"PLoS ONE"},{"issue":"23","key":"1347_CR51","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/ajhp\/zxac244","volume":"79","author":"JD LeFevre","year":"2022","unstructured":"LeFevre, J. D., Cyriac, S. L., Tokmic, A., & Pitlick, J. M. (2022). Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature review. American Journal of Health-System Pharmacy, 79(23), 2099\u20132117.","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"3","key":"1347_CR52","doi-asserted-by":"publisher","first-page":"143","DOI":"10.6065\/apem.2019.24.3.143","volume":"24","author":"HS Lee","year":"2019","unstructured":"Lee, H. S., & Hwang, J. S. (2019). Genetic aspects of type 1 diabetes. Annals of Pediatric Endocrinology & Metabolism, 24(3), 143.","journal-title":"Annals of Pediatric Endocrinology & Metabolism"},{"issue":"15","key":"1347_CR53","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/ijms21155238","volume":"21","author":"F Pandolfi","year":"2020","unstructured":"Pandolfi, F., et al. (2020). Interleukin-6 in rheumatoid arthritis. International Journal of Molecular Sciences, 21(15), 5238.","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"1347_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102617","volume":"19","author":"P Migliorini","year":"2020","unstructured":"Migliorini, P., et al. (2020). The IL-1 family cytokines and receptors in autoimmune diseases. Autoimmunity Reviews, 19(9), 102617.","journal-title":"Autoimmunity Reviews"},{"key":"1347_CR55","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2019.02025","volume":"10","author":"D Xu","year":"2019","unstructured":"Xu, D., Mu, R., & Wei, X. (2019). The roles of IL-1 family cytokines in the pathogenesis of systemic sclerosis. Frontiers in Immunology, 10, 2025.","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"1347_CR56","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1038\/s41598-017-03759-w","volume":"7","author":"MJ Pearson","year":"2017","unstructured":"Pearson, M. J., et al. (2017). IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity. Scientific Reports, 7(1), 3451.","journal-title":"Scientific Reports"},{"issue":"8","key":"1347_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41584-019-0243-5","volume":"15","author":"A Beringer","year":"2019","unstructured":"Beringer, A., & Miossec, P. (2019). Systemic effects of IL-17 in inflammatory arthritis. Nature Reviews Rheumatology, 15(8), 491\u2013501.","journal-title":"Nature Reviews Rheumatology"},{"issue":"10","key":"1347_CR58","doi-asserted-by":"publisher","first-page":"17159","DOI":"10.1002\/jcp.28495","volume":"234","author":"FS Mohammadi","year":"2019","unstructured":"Mohammadi, F. S., et al. (2019). Are genetic variations in IL-21\u2013IL-23R\u2013IL-17A cytokine axis involved in a pathogenic pathway of rheumatoid arthritis? Bayesian hierarchical meta-analysis. Journal of Cellular Physiology, 234(10), 17159\u201317171.","journal-title":"Journal of Cellular Physiology"},{"issue":"14","key":"1347_CR59","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.3390\/ijms20143394","volume":"20","author":"K Bunte","year":"2019","unstructured":"Bunte, K., & Beikler, T. (2019). Th17 cells and the IL-23\/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases. International Journal of Molecular Sciences, 20(14), 3394.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1347_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen, Z., Bozec, A., Ramming, A., & Schett, G. (2019). Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nature Reviews Rheumatology, 15(1), 9\u201317.","journal-title":"Nature Reviews Rheumatology"},{"issue":"2","key":"1347_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00365521.2016.1246605","volume":"52","author":"GL Jakobsson","year":"2017","unstructured":"Jakobsson, G. L., et al. (2017). Validating inflammatory bowel disease (IBD) in the Swedish National Patient Register and the Swedish Quality Register for IBD (SWIBREG). Scandinavian Journal of Gastroenterology, 52(2), 216\u2013221.","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"1347_CR62","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40259-020-00451-w","volume":"34","author":"A Almradi","year":"2020","unstructured":"Almradi, A., et al. (2020). Clinical trials of IL-12\/IL-23 inhibitors in inflammatory bowel disease. BioDrugs, 34, 713\u2013721.","journal-title":"BioDrugs"},{"key":"1347_CR63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00011-014-0768-7","volume":"63","author":"W Jiang","year":"2014","unstructured":"Jiang, W., et al. (2014). Elevated levels of Th17 cells and Th17-related cytokines are associated with disease activity in patients with inflammatory bowel disease. Inflammation Research, 63, 943\u2013950.","journal-title":"Inflammation Research"},{"key":"1347_CR64","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s10753-019-01066-2","volume":"42","author":"H Shahid","year":"2019","unstructured":"Shahid, H., Shahzad, M., Shabbir, A., & Saghir, G. (2019). Immunomodulatory and anti-inflammatory potential of curcumin for the treatment of allergic asthma: Effects on expression levels of pro-inflammatory cytokines and aquaporins. Inflammation, 42, 2037\u20132047.","journal-title":"Inflammation"},{"issue":"1","key":"1347_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01474-x","volume":"20","author":"J Ju","year":"2020","unstructured":"Ju, J., et al. (2020). Crohn\u2019s disease exacerbated by IL-17 inhibitors in patients with psoriasis: A case report. BMC Gastroenterology, 20(1), 1\u20137.","journal-title":"BMC Gastroenterology"},{"key":"1347_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2023.156123","volume":"164","author":"W Hu","year":"2023","unstructured":"Hu, W., et al. (2023). MiR-149-5p inhibits cell proliferation, promotes cell apoptosis and retards cell cycle of IL-22-stimulated HaCaT and NHEK keratinocytes via regulating PDE4D. Cytokine, 164, 156123.","journal-title":"Cytokine"},{"issue":"13","key":"1347_CR67","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.7150\/ijbs.38925","volume":"16","author":"Y Wu","year":"2020","unstructured":"Wu, Y., et al. (2020). Interleukin 22 in liver injury, inflammation and cancer. International Journal of Biological Sciences, 16(13), 2405.","journal-title":"International Journal of Biological Sciences"},{"issue":"8","key":"1347_CR68","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/eji.201646710","volume":"47","author":"KG Schmetterer","year":"2017","unstructured":"Schmetterer, K. G., & Pickl, W. F. (2017). The IL\u201310\/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells. European Journal of Immunology, 47(8), 1256\u20131265.","journal-title":"European Journal of Immunology"},{"issue":"36","key":"1347_CR69","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.3748\/wjg.v24.i36.4093","volume":"24","author":"I Aggeletopoulou","year":"2018","unstructured":"Aggeletopoulou, I., Assimakopoulos, S. F., Konstantakis, C., & Triantos, C. (2018). Interleukin 12\/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn\u2019s disease. World Journal of Gastroenterology, 24(36), 4093.","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"1347_CR70","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5114\/reum.2020.98434","volume":"58","author":"Y Adel","year":"2020","unstructured":"Adel, Y., & Sadeq, Y. (2020). Impact of IL-34, IFN-\u03b1 and IFN-\u03bb1 on activity of systemic lupus erythematosus in Egyptian patients. Reumatologia\/Rheumatology, 58(4), 221\u2013230.","journal-title":"Reumatologia\/Rheumatology"},{"issue":"3","key":"1347_CR71","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","volume":"16","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli, C., & Moroni, G. (2017). Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opinion on Drug Safety, 16(3), 411\u2013419.","journal-title":"Expert Opinion on Drug Safety"},{"key":"1347_CR72","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.intimp.2018.12.001","volume":"67","author":"Z Li","year":"2019","unstructured":"Li, Z., et al. (2019). Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia. International Immunopharmacology, 67, 268\u2013280.","journal-title":"International Immunopharmacology"},{"issue":"4","key":"1347_CR73","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/1744666X.2022.2045952","volume":"18","author":"FF Kreiner","year":"2022","unstructured":"Kreiner, F. F., et al. (2022). Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: Mechanisms and therapeutic perspectives. Expert Review of Clinical Immunology, 18(4), 377\u2013389.","journal-title":"Expert Review of Clinical Immunology"},{"issue":"3","key":"1347_CR74","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1615\/CritRevEukaryotGeneExpr.2017019712","volume":"27","author":"K Rehman","year":"2017","unstructured":"Rehman, K., et al. (2017). Role of interleukin-6 in development of insulin resistance and type 2 diabetes mellitus. Critical Reviews\u2122 in Eukaryotic Gene Expression, 27(3), 229.","journal-title":"Critical Reviews\u2122 in Eukaryotic Gene Expression"},{"issue":"1","key":"1347_CR75","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/10408398.2017.1358139","volume":"59","author":"H Mollazadeh","year":"2019","unstructured":"Mollazadeh, H., et al. (2019). Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition, 59(1), 89\u2013101.","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"5","key":"1347_CR76","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1007\/s11033-022-07221-7","volume":"49","author":"B Mahmoud","year":"2022","unstructured":"Mahmoud, B., Abdel-Moneim, A., Negeem, Z., & Nabil, A. (2022). The relationship between B-cell lymphoma 2, interleukin-1\u03b2, interleukin-17, and interleukin-33 and the development of diabetic nephropathy. Molecular Biology Reports, 49(5), 3803\u20133809.","journal-title":"Molecular Biology Reports"},{"issue":"1","key":"1347_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-021-00326-y","volume":"27","author":"X Chen","year":"2021","unstructured":"Chen, X., et al. (2021). LncRNA H19 induces immune dysregulation of BMMSCs, at least partly, by inhibiting IL-2 production. Molecular Medicine, 27(1), 1\u201311.","journal-title":"Molecular Medicine"},{"issue":"6","key":"1347_CR78","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1093\/rheumatology\/keab950","volume":"61","author":"I Nakajima","year":"2022","unstructured":"Nakajima, I., et al. (2022). Therapeutic potential of the interleukin-4\/interleukin-13 inhibitor dupilumab for treating IgG4-related disease. Rheumatology, 61(6), e151\u2013e153.","journal-title":"Rheumatology"},{"issue":"1","key":"1347_CR79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.autrev.2018.06.015","volume":"18","author":"A Mirouse","year":"2019","unstructured":"Mirouse, A., et al. (2019). Arthritis in primary Sj\u00f6gren\u2019s syndrome: Characteristics, outcome and treatment from French multicenter retrospective study. Autoimmunity Reviews, 18(1), 9\u201314.","journal-title":"Autoimmunity Reviews"},{"issue":"12","key":"1347_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102690","volume":"19","author":"M Bautista-Vargas","year":"2020","unstructured":"Bautista-Vargas, M., Vivas, A. J., & Tob\u00f3n, G. J. (2020). Minor salivary gland biopsy: Its role in the classification and prognosis of Sj\u00f6gren\u2019s syndrome. Autoimmunity Reviews, 19(12), 102690.","journal-title":"Autoimmunity Reviews"},{"key":"1347_CR81","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","volume":"182","author":"AV Goules","year":"2017","unstructured":"Goules, A. V., Kapsogeorgou, E. K., & Tzioufas, A. G. (2017). Insight into pathogenesis of Sj\u00f6gren\u2019s syndrome: Dissection on autoimmune infiltrates and epithelial cells. Clinical Immunology, 182, 30\u201340.","journal-title":"Clinical Immunology"},{"issue":"9","key":"1347_CR82","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.3390\/jcm9093057","volume":"9","author":"R Witas","year":"2020","unstructured":"Witas, R., Gupta, S., & Nguyen, C. Q. (2020). Contributions of major cell populations to Sj\u00f6gren\u2019s syndrome. Journal of Clinical Medicine, 9(9), 3057.","journal-title":"Journal of Clinical Medicine"},{"key":"1347_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00039-0","author":"S Gandolfo","year":"2024","unstructured":"Gandolfo, S., et al. (2024). Precision medicine in Sj\u00f6gren\u2019s disease. The Lancet Rheumatology. https:\/\/doi.org\/10.1016\/S2665-9913(24)00039-0","journal-title":"The Lancet Rheumatology"},{"issue":"10","key":"1347_CR84","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2665-9913(24)00183-8","volume":"6","author":"AV Goules","year":"2024","unstructured":"Goules, A. V., et al. (2024). Identification and evolution of predictors of Sj\u00f6gren\u2019s disease-associated mucosa-associated lymphoid tissue lymphoma development over time: A case-control study. The Lancet Rheumatology, 6(10), e693\u2013e702.","journal-title":"The Lancet Rheumatology"},{"issue":"3","key":"1347_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102763","volume":"20","author":"G Cavalli","year":"2021","unstructured":"Cavalli, G., et al. (2021). Interleukin 1\u03b1: A comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmunity reviews, 20(3), 102763.","journal-title":"Autoimmunity reviews"},{"key":"1347_CR86","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133652","author":"Y Tong","year":"2020","unstructured":"Tong, Y., et al. (2020). The RNFT2\/IL-3R\u03b1 axis regulates IL-3 signaling and innate immunity. JCI insight. https:\/\/doi.org\/10.1172\/jci.insight.133652","journal-title":"JCI insight"},{"key":"1347_CR87","doi-asserted-by":"publisher","first-page":"1023177","DOI":"10.3389\/fonc.2022.1023177","volume":"12","author":"B Huang","year":"2022","unstructured":"Huang, B., Lang, X., & Li, X. (2022). The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers. Frontiers in Oncology, 12, 1023177.","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"1347_CR88","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000505099","volume":"98","author":"P Uciechowski","year":"2020","unstructured":"Uciechowski, P., & Dempke, W. (2020). Interleukin-6: A masterplayer in the cytokine network. Oncology, 98(3), 131\u2013137.","journal-title":"Oncology"},{"key":"1347_CR89","volume-title":"Interleukin, in StatPearls [Internet]","author":"AAJ Vaillant","year":"2022","unstructured":"Vaillant, A. A. J., & Qurie, A. (2022). Interleukin, in StatPearls [Internet]. StatPearls Publishing."},{"issue":"7","key":"1347_CR90","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3390\/cells8070685","volume":"8","author":"S-C Lin","year":"2019","unstructured":"Lin, S.-C., Shi, L.-S., & Ye, Y.-L. (2019). Advanced molecular knowledge of therapeutic drugs and natural products focusing on inflammatory cytokines in asthma. Cells, 8(7), 685.","journal-title":"Cells"},{"issue":"10","key":"1347_CR91","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/21645515.2020.1717185","volume":"16","author":"G Ni","year":"2020","unstructured":"Ni, G., et al. (2020). Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task. Human Vaccines & Immunotherapeutics, 16(10), 2328\u20132332.","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"1","key":"1347_CR92","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","volume":"9","author":"M Yi","year":"2024","unstructured":"Yi, M., et al. (2024). Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduction and Targeted Therapy, 9(1), 176.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"1347_CR93","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3390\/cancers13020167","volume":"13","author":"B Mirlekar","year":"2021","unstructured":"Mirlekar, B., & Pylayeva-Gupta, Y. (2021). IL-12 family cytokines in cancer and immunotherapy. Cancers, 13(2), 167.","journal-title":"Cancers"},{"key":"1347_CR94","doi-asserted-by":"publisher","first-page":"1321318","DOI":"10.3389\/fonc.2023.1321318","volume":"13","author":"CM Minnar","year":"2024","unstructured":"Minnar, C. M., et al. (2024). Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine. Frontiers in Oncology, 13, 1321318.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"1347_CR95","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/imr.12615","volume":"281","author":"A Malik","year":"2018","unstructured":"Malik, A., & Kanneganti, T. D. (2018). Function and regulation of IL-1\u03b1 in inflammatory diseases and cancer. Immunological Reviews, 281(1), 124\u2013137.","journal-title":"Immunological Reviews"},{"issue":"2","key":"1347_CR96","doi-asserted-by":"publisher","first-page":"327","DOI":"10.23812\/CONTI-E","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti, P., et al. (2020). Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): Anti-inflammatory strategies. Journal of Biological Regulators and Homeostatic Agents, 34(2), 327\u2013331.","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"issue":"1","key":"1347_CR97","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJ Arts","year":"2018","unstructured":"Arts, R. J., et al. (2018). BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host & Microbe, 23(1), 89-100.e5.","journal-title":"Cell Host & Microbe"},{"key":"1347_CR98","first-page":"1","volume":"2020","author":"Q Fang","year":"2020","unstructured":"Fang, Q., Zhou, C., & Nandakumar, K. S. (2020). Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators of Inflammation, 2020, 1\u201320.","journal-title":"Mediators of Inflammation"},{"key":"1347_CR99","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fimmu.2019.00692","volume":"10","author":"A Gabryelska","year":"2019","unstructured":"Gabryelska, A., et al. (2019). IL-33 mediated inflammation in chronic respiratory diseases\u2014understanding the role of the member of IL-1 superfamily. Frontiers in Immunology, 10, 692.","journal-title":"Frontiers in Immunology"},{"key":"1347_CR100","volume-title":"Cytokine profiling plays a crucial role in activating immune system to clear infectious pathogens, in Immune response activation and immunomodulation","author":"JL Mu\u00f1oz-Carrillo","year":"2018","unstructured":"Mu\u00f1oz-Carrillo, J. L., et al. (2018). Cytokine profiling plays a crucial role in activating immune system to clear infectious pathogens, in Immune response activation and immunomodulation. IntechOpen."},{"issue":"1","key":"1347_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01603-z","volume":"11","author":"R Kuhikar","year":"2020","unstructured":"Kuhikar, R., et al. (2020). Transforming growth factor \u03b21 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy. Stem Cell Research & Therapy, 11(1), 1\u201315.","journal-title":"Stem Cell Research & Therapy"},{"issue":"1","key":"1347_CR102","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1038\/s41467-021-22898-3","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X., et al. (2021). Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeutic. Nature Communications, 12(1), 2637.","journal-title":"Nature Communications"},{"issue":"1","key":"1347_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-018-0268-4","volume":"16","author":"MM Zegeye","year":"2018","unstructured":"Zegeye, M. M., et al. (2018). Activation of the JAK\/STAT3 and PI3K\/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Cell Communication and Signaling, 16(1), 1\u201310.","journal-title":"Cell Communication and Signaling"},{"key":"1347_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.601641","volume":"7","author":"S Wang","year":"2021","unstructured":"Wang, S., et al. (2021). Cytokine storm in domestic pigs induced by infection of virulent African swine fever virus. Frontiers in Veterinary Science, 7, 601641.","journal-title":"Frontiers in Veterinary Science"},{"issue":"5","key":"1347_CR105","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/biomedicines8050101","volume":"8","author":"BZ Johnson","year":"2020","unstructured":"Johnson, B. Z., et al. (2020). The role of IL-6 in skin fibrosis and cutaneous wound healing. Biomedicines, 8(5), 101.","journal-title":"Biomedicines"},{"issue":"7","key":"1347_CR106","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s12276-021-00649-0","volume":"53","author":"S Kang","year":"2021","unstructured":"Kang, S., & Kishimoto, T. (2021). Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Experimental & Molecular Medicine, 53(7), 1116\u20131123.","journal-title":"Experimental & Molecular Medicine"},{"issue":"1","key":"1347_CR107","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jaci.2017.02.035","volume":"141","author":"M Hussain","year":"2018","unstructured":"Hussain, M., et al. (2018). Basophil-derived IL-4 promotes epicutaneous antigen sensitization concomitant with the development of food allergy. Journal of Allergy and Clinical Immunology, 141(1), 223-234.e5.","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"1347_CR108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ebiom.2018.01.028","volume":"29","author":"S-Y Weng","year":"2018","unstructured":"Weng, S.-Y., et al. (2018). IL-4 receptor alpha signaling through macrophages differentially regulates liver fibrosis progression and reversal. eBioMedicine, 29, 92\u2013103.","journal-title":"eBioMedicine"},{"key":"1347_CR109","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","volume":"9","author":"IS Junttila","year":"2018","unstructured":"Junttila, I. S. (2018). Tuning the cytokine responses: An update on interleukin (IL)-4 and IL-13 receptor complexes. Frontiers in Immunology, 9, 888.","journal-title":"Frontiers in Immunology"},{"key":"1347_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101373","volume":"28","author":"X Li","year":"2020","unstructured":"Li, X., et al. (2020). Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells. Redox Biology, 28, 101373.","journal-title":"Redox Biology"},{"key":"1347_CR111","doi-asserted-by":"publisher","DOI":"10.36468\/pharmaceutical-sciences.548","author":"K Wolska","year":"2019","unstructured":"Wolska, K., Gorska, A., Antosik, K., & \u0141ugowska, K. (2019). Immunomodulatory effects of propolis and its components on basic immune cell functions. Indian Journal of Pharmaceutical Sciences. https:\/\/doi.org\/10.36468\/pharmaceutical-sciences.548","journal-title":"Indian Journal of Pharmaceutical Sciences"},{"issue":"6337","key":"1347_CR112","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1126\/science.aal3535","volume":"356","author":"WE Ip","year":"2017","unstructured":"Ip, W. E., et al. (2017). Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science, 356(6337), 513\u2013519.","journal-title":"Science"},{"issue":"2","key":"1347_CR113","first-page":"595","volume":"42","author":"L Chen","year":"2019","unstructured":"Chen, L., et al. (2019). IL-10 secreted by cancer-associated macrophages regulates proliferation and invasion in gastric cancer cells via c-Met\/STAT3 signaling. Oncology Reports, 42(2), 595\u2013604.","journal-title":"Oncology Reports"},{"issue":"3","key":"1347_CR114","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41575-018-0084-8","volume":"16","author":"AR Moschen","year":"2019","unstructured":"Moschen, A. R., Tilg, H., & Raine, T. (2019). IL-12, IL-23 and IL-17 in IBD: Immunobiology and therapeutic targeting. Nature Reviews Gastroenterology & Hepatology, 16(3), 185\u2013196.","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"1347_CR115","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-10811-3_3","author":"F Broere","year":"2019","unstructured":"Broere, F., & van Eden, W. (2019). T cell subsets and T cell-mediated immunity. Nijkamp and Parnham\u2019s Principles of Immunopharmacology. https:\/\/doi.org\/10.1007\/978-3-030-10811-3_3","journal-title":"Nijkamp and Parnham\u2019s Principles of Immunopharmacology"},{"issue":"9","key":"1347_CR116","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/v11090772","volume":"11","author":"Y Guo","year":"2019","unstructured":"Guo, Y., Cao, W., & Zhu, Y. (2019). Immunoregulatory functions of the IL-12 family of cytokines in antiviral systems. Viruses, 11(9), 772.","journal-title":"Viruses"},{"issue":"1","key":"1347_CR117","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/eji.201847677","volume":"49","author":"A Mazzoni","year":"2019","unstructured":"Mazzoni, A., et al. (2019). Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation. European Journal of Immunology, 49(1), 79\u201395.","journal-title":"European Journal of Immunology"},{"key":"1347_CR118","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molimm.2017.06.025","volume":"88","author":"E Lusty","year":"2017","unstructured":"Lusty, E., et al. (2017). IL-18\/IL-15\/IL-12 synergy induces elevated and prolonged IFN-\u03b3 production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation. Molecular Immunology, 88, 138\u2013147.","journal-title":"Molecular Immunology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01347-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01347-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01347-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:14:22Z","timestamp":1779797662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01347-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":118,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01347-8","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}